[go: up one dir, main page]

FR2781221B1 - Piperazinones substituees en alpha - Google Patents

Piperazinones substituees en alpha

Info

Publication number
FR2781221B1
FR2781221B1 FR9809169A FR9809169A FR2781221B1 FR 2781221 B1 FR2781221 B1 FR 2781221B1 FR 9809169 A FR9809169 A FR 9809169A FR 9809169 A FR9809169 A FR 9809169A FR 2781221 B1 FR2781221 B1 FR 2781221B1
Authority
FR
France
Prior art keywords
alpha substituted
substituted piperazinones
piperazinones
alpha
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9809169A
Other languages
English (en)
Other versions
FR2781221A1 (fr
Inventor
Christophe Yue
Marguerite Henry
Thierry Giboulot
Brigitte Lesur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9809169A priority Critical patent/FR2781221B1/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to JP2000560108A priority patent/JP2002520402A/ja
Priority to CNB998087327A priority patent/CN1173957C/zh
Priority to EP99929498A priority patent/EP1098889A1/fr
Priority to EA200100152A priority patent/EA003430B1/ru
Priority to PCT/FR1999/001751 priority patent/WO2000004001A1/fr
Priority to CA002337880A priority patent/CA2337880A1/fr
Priority to US09/743,352 priority patent/US6335337B1/en
Priority to AU46293/99A priority patent/AU751981B2/en
Priority to BR9912153-0A priority patent/BR9912153A/pt
Priority to NZ509167A priority patent/NZ509167A/en
Publication of FR2781221A1 publication Critical patent/FR2781221A1/fr
Application granted granted Critical
Publication of FR2781221B1 publication Critical patent/FR2781221B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9809169A 1998-07-17 1998-07-17 Piperazinones substituees en alpha Expired - Fee Related FR2781221B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR9809169A FR2781221B1 (fr) 1998-07-17 1998-07-17 Piperazinones substituees en alpha
AU46293/99A AU751981B2 (en) 1998-07-17 1999-07-16 Substituted piperazones and their therapeutic uses
EP99929498A EP1098889A1 (fr) 1998-07-17 1999-07-16 Piperazinones substituees et leurs applications en therapeutique
EA200100152A EA003430B1 (ru) 1998-07-17 1999-07-16 Замещенные пиперазиноны и их терапевтическое применение
PCT/FR1999/001751 WO2000004001A1 (fr) 1998-07-17 1999-07-16 Piperazinones substituees et leurs applications en therapeutique
CA002337880A CA2337880A1 (fr) 1998-07-17 1999-07-16 Piperazinones substituees et leurs applications en therapeutique
JP2000560108A JP2002520402A (ja) 1998-07-17 1999-07-16 置換ピペラジノン及びその治療的使用
CNB998087327A CN1173957C (zh) 1998-07-17 1999-07-16 取代的哌嗪酮及其治疗应用
BR9912153-0A BR9912153A (pt) 1998-07-17 1999-07-16 Piperazinonas substituìdas e uso terapêuticos das mesmas
NZ509167A NZ509167A (en) 1998-07-17 1999-07-16 Substituted piperazones useful as antithrombotic agents
US09/743,352 US6335337B1 (en) 1998-07-17 1999-07-16 Substituted piperazinones and their therapeutic uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809169A FR2781221B1 (fr) 1998-07-17 1998-07-17 Piperazinones substituees en alpha

Publications (2)

Publication Number Publication Date
FR2781221A1 FR2781221A1 (fr) 2000-01-21
FR2781221B1 true FR2781221B1 (fr) 2000-10-13

Family

ID=9528735

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9809169A Expired - Fee Related FR2781221B1 (fr) 1998-07-17 1998-07-17 Piperazinones substituees en alpha

Country Status (11)

Country Link
US (1) US6335337B1 (fr)
EP (1) EP1098889A1 (fr)
JP (1) JP2002520402A (fr)
CN (1) CN1173957C (fr)
AU (1) AU751981B2 (fr)
BR (1) BR9912153A (fr)
CA (1) CA2337880A1 (fr)
EA (1) EA003430B1 (fr)
FR (1) FR2781221B1 (fr)
NZ (1) NZ509167A (fr)
WO (1) WO2000004001A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290136B (en) 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
US7521473B2 (en) 2004-02-25 2009-04-21 Wyeth Inhibitors of protein tyrosine phosphatase 1B
HUE029336T2 (en) * 2005-09-16 2017-02-28 Daiichi Sankyo Co Ltd For the preparation of an optically active diamine derivative and process
JP5475864B2 (ja) * 2009-03-30 2014-04-16 ドン ア ファーマシューティカル カンパニー リミテッド ジペプチジルペプチダーゼ−ｉｖ阻害剤及び中間体の改良された製造方法
WO2013082210A1 (fr) * 2011-11-29 2013-06-06 Perosphere Inc. Agents inversant l'effet des anticoagulants
GB201412545D0 (en) * 2014-07-15 2014-08-27 Univ Manchester The And Manchester Metropolitan University Enzymatic processes and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4302485A1 (de) * 1993-01-29 1994-08-04 Merck Patent Gmbh Piperazinderivate

Also Published As

Publication number Publication date
WO2000004001A1 (fr) 2000-01-27
US6335337B1 (en) 2002-01-01
AU4629399A (en) 2000-02-07
CN1314895A (zh) 2001-09-26
AU751981B2 (en) 2002-09-05
EA003430B1 (ru) 2003-04-24
CN1173957C (zh) 2004-11-03
CA2337880A1 (fr) 2000-01-27
JP2002520402A (ja) 2002-07-09
EP1098889A1 (fr) 2001-05-16
FR2781221A1 (fr) 2000-01-21
EA200100152A1 (ru) 2001-06-25
NZ509167A (en) 2003-08-29
BR9912153A (pt) 2001-04-10

Similar Documents

Publication Publication Date Title
ATE341990T1 (de) Sigmidoskop
DE59902874D1 (de) Buchsenkontakt
DE59901560D1 (de) Retrograder tibianagel
NO990113D0 (no) Flerskrog-fart°y
DE59907306D1 (de) Fadenchangierung
DE69905536D1 (de) Gyriconscheibe
ID23761A (id) Trisiklik tersubstitusi
DK0885212T3 (da) Quinoxalindioner
DE59906931D1 (de) Exzenterzahnradgetriebe
DE69902762D1 (de) Riser-spannanordnung
ATE262513T1 (de) Benzoylpyridazine
DE59903966D1 (de) Exzenterzahnradgetriebe
ID23219A (id) Trisiklik tersubstitusi
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59807217D1 (de) Nadellager
DE59808995D1 (de) Endomikroskopsystem
FR2781221B1 (fr) Piperazinones substituees en alpha
FI980759A0 (fi) Taetningskonstruktion foer suglaodan i en sugvals
DE19842103B4 (de) Stanznietzuführung
DE59911610D1 (de) Substituierte benzoylcyclohexandione
DE59911393D1 (de) Ausdrehkopf
DE59902088D1 (de) Achrathermer Reimager
DE59903616D1 (de) Rollenwicklerwalze
DE59900612D1 (de) Dispersionsazofarbstoffmischungen

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090331